|
UBE2N expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55299999526903E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.59080000014822E-07 |
| Normal-vs-Stage2 |
4.974200E-04 |
| Normal-vs-Stage3 |
1.98440999999994E-05 |
| Normal-vs-Stage4 |
3.63290000304772E-08 |
| Stage1-vs-Stage2 |
9.017200E-01 |
| Stage1-vs-Stage3 |
4.848400E-01 |
| Stage1-vs-Stage4 |
1.879200E-01 |
| Stage2-vs-Stage3 |
5.227200E-01 |
| Stage2-vs-Stage4 |
2.903400E-01 |
| Stage3-vs-Stage4 |
7.676400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.11700000044502E-08 |
| Normal-vs-AfricanAmerican |
7.40799999121577E-09 |
| Normal-vs-Asian |
7.542700E-03 |
| Caucasian-vs-AfricanAmerican |
5.264100E-02 |
| Caucasian-vs-Asian |
3.679000E-01 |
| AfricanAmerican-vs-Asian |
9.380800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.85470005809441E-10 |
| Normal-vs-Female |
3.629000E-04 |
| Male-vs-Female |
1.492410E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.622580E-04 |
| Normal-vs-Age(41-60Yrs) |
8.24600000504105E-08 |
| Normal-vs-Age(61-80Yrs) |
3.21789999979671E-07 |
| Normal-vs-Age(81-100Yrs) |
6.857500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.460200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.062600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.878400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.033000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.805400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.750400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.225700E-02 |
| Normal-vs-Grade 2 |
1.402910E-04 |
| Normal-vs-Grade 3 |
3.14710002502494E-09 |
| Normal-vs-Grade 4 |
1.8051999894908E-09 |
| Grade 1-vs-Grade 2 |
8.242000E-01 |
| Grade 1-vs-Grade 3 |
2.914000E-01 |
| Grade 1-vs-Grade 4 |
8.262200E-02 |
| Grade 2-vs-Grade 3 |
1.653510E-02 |
| Grade 2-vs-Grade 4 |
2.904700E-03 |
| Grade 3-vs-Grade 4 |
3.473800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.339500E-03 |
| Normal-vs-ccB subtype |
2.38240005501211E-09 |
| ccA subtype-vs-ccB subtype |
1.012170E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.34120000017913E-07 |
| Normal-vs-N1 |
8.543200E-01 |
| N0-vs-N1 |
5.400400E-01 |
|
|
